DE2246013A1 - Verfahren zur herstellung von poroesen tabletten - Google Patents

Verfahren zur herstellung von poroesen tabletten

Info

Publication number
DE2246013A1
DE2246013A1 DE2246013A DE2246013A DE2246013A1 DE 2246013 A1 DE2246013 A1 DE 2246013A1 DE 2246013 A DE2246013 A DE 2246013A DE 2246013 A DE2246013 A DE 2246013A DE 2246013 A1 DE2246013 A1 DE 2246013A1
Authority
DE
Germany
Prior art keywords
tablets
tablet
excipient
urethane
mixed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE2246013A
Other languages
German (de)
English (en)
Inventor
Helmut Dr Rer Nat Heinemann
Werner Dr Rer Nat Rothe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim GmbH filed Critical Boehringer Mannheim GmbH
Priority to DE2246013A priority Critical patent/DE2246013A1/de
Priority to US395796A priority patent/US3885026A/en
Priority to GB4318773A priority patent/GB1381588A/en
Priority to IT7328973A priority patent/IT998618B/it
Priority to CH1329273A priority patent/CH579394A5/xx
Priority to FR7333392A priority patent/FR2199973B1/fr
Priority to SE7312753A priority patent/SE395366B/xx
Priority to AT806973A priority patent/AT324568B/de
Priority to JP48106458A priority patent/JPS4969819A/ja
Publication of DE2246013A1 publication Critical patent/DE2246013A1/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S516/00—Colloid systems and wetting agents; subcombinations thereof; processes of
    • Y10S516/01—Wetting, emulsifying, dispersing, or stabilizing agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
DE2246013A 1972-09-20 1972-09-20 Verfahren zur herstellung von poroesen tabletten Pending DE2246013A1 (de)

Priority Applications (9)

Application Number Priority Date Filing Date Title
DE2246013A DE2246013A1 (de) 1972-09-20 1972-09-20 Verfahren zur herstellung von poroesen tabletten
US395796A US3885026A (en) 1972-09-20 1973-09-10 Preparation of porous tablets
GB4318773A GB1381588A (en) 1972-09-20 1973-09-14 Process for the preparation of porous tablets
IT7328973A IT998618B (it) 1972-09-20 1973-09-17 Procedimento per la produzione di pastiglie porose
CH1329273A CH579394A5 (enExample) 1972-09-20 1973-09-17
FR7333392A FR2199973B1 (enExample) 1972-09-20 1973-09-18
SE7312753A SE395366B (sv) 1972-09-20 1973-09-19 Forfarande for framstellning av porosa tabletter
AT806973A AT324568B (de) 1972-09-20 1973-09-19 Verfahren zur herstellung von porosen tabletten
JP48106458A JPS4969819A (enExample) 1972-09-20 1973-09-20

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2246013A DE2246013A1 (de) 1972-09-20 1972-09-20 Verfahren zur herstellung von poroesen tabletten

Publications (1)

Publication Number Publication Date
DE2246013A1 true DE2246013A1 (de) 1974-03-28

Family

ID=5856791

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2246013A Pending DE2246013A1 (de) 1972-09-20 1972-09-20 Verfahren zur herstellung von poroesen tabletten

Country Status (9)

Country Link
US (1) US3885026A (enExample)
JP (1) JPS4969819A (enExample)
AT (1) AT324568B (enExample)
CH (1) CH579394A5 (enExample)
DE (1) DE2246013A1 (enExample)
FR (1) FR2199973B1 (enExample)
GB (1) GB1381588A (enExample)
IT (1) IT998618B (enExample)
SE (1) SE395366B (enExample)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2556561A1 (de) * 1975-12-16 1977-06-30 Boehringer Mannheim Gmbh Verfahren zur herstellung von poroesen tabletten
DE2744493A1 (de) * 1976-10-06 1978-04-13 Wyeth John & Brother Ltd Geformter traeger fuer chemikalien und/oder pharmaka
DE3734796A1 (de) * 1986-10-14 1988-04-21 Beaufour Lab Verfahren zur herstellung von loeslichen und/oder zerteilbaren tabletten und nach diesem verfahren erhaltene tabletten
WO2024252015A1 (de) 2023-06-09 2024-12-12 euvorio GmbH Verwendung kohlenhydrathaltiger zusammensetzungen in tablettenform zur behandlung von hypoglykämiezuständen

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4080433A (en) * 1975-03-10 1978-03-21 University Of Southern California Process for the catalytic oxidation of hydrocarbons with the oxides of nitrogen
GB1548022A (en) * 1976-10-06 1979-07-04 Wyeth John & Brother Ltd Pharmaceutial dosage forms
US4568547A (en) * 1979-08-30 1986-02-04 Herschler R J Solid pharmaceutical compositions comprising MSM and their production
US4883182A (en) * 1985-05-31 1989-11-28 Hughes Raymond J Tamper evident capsule and insert device
ATE138563T1 (de) * 1991-12-20 1996-06-15 Pfizer Poröse geformte abgabevorrichtung und verfahren zur herstellung derselbe
ES2096103T3 (es) * 1992-01-13 1997-03-01 Pfizer Preparacion de comprimidos de resistencia incrementada.
HUT75616A (en) * 1992-03-17 1997-05-28 Pfizer Method for prooucing porous delivery devices
DE69332105T2 (de) 1992-09-29 2003-03-06 Inhale Therapeutic Systems, San Carlos Pulmonale abgabe von aktiven fragmenten des parathormons
EP0748213B1 (en) 1994-03-07 2004-04-14 Nektar Therapeutics Methods and compositions for pulmonary delivery of insulin
US6586006B2 (en) 1994-08-04 2003-07-01 Elan Drug Delivery Limited Solid delivery systems for controlled release of molecules incorporated therein and methods of making same
US6290991B1 (en) 1994-12-02 2001-09-18 Quandrant Holdings Cambridge Limited Solid dose delivery vehicle and methods of making same
JPH10508744A (ja) 1994-09-22 1998-09-02 クオドラント ホールディングス ケンブリッジ リミテッド 運動競技の間の水分補給および栄養摂取の用途のための組成物ならびにその製造法
US6964771B1 (en) 1995-06-07 2005-11-15 Elan Drug Delivery Limited Method for stably incorporating substances within dry, foamed glass matrices
US5762961A (en) * 1996-02-09 1998-06-09 Quadrant Holdings Cambridge Ltd. Rapidly soluble oral solid dosage forms, methods of making same, and compositions thereof
US5958455A (en) * 1996-02-09 1999-09-28 Quadrant Holdings Cambridge Ltd Oral solid dosage forms, methods of making same and compositions thereof
US6632648B1 (en) 1996-05-14 2003-10-14 Elan Drug Delivery Limited Methods of terminal sterilization of fibrinogen
DE69733476T2 (de) * 1996-06-14 2006-03-23 Kyowa Hakko Kogyo Co., Ltd. Im munde schnellzerfallende tablette
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
KR100481583B1 (ko) * 1996-06-14 2005-07-12 교와 핫꼬 고교 가부시끼가이샤 구강내에서빠르게붕괴하는정제
EA000913B1 (ru) 1996-08-13 2000-06-26 Кийова Хакко Когио Ко., Лтд. Таблетка меченной изотопом мочевины
US6468782B1 (en) 1996-12-05 2002-10-22 Quadrant Healthcare (Uk) Limited Methods of preserving prokaryotic cells and compositions obtained thereby
US20040023948A1 (en) * 1997-03-24 2004-02-05 Green Richard David Fast-dispersing dosage form containing 5-HT1 agonists
US6309623B1 (en) 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
GT199900061A (es) * 1998-05-15 2000-10-14 Pfizer Formulaciones farmaceuticas.
RU2140262C1 (ru) * 1998-06-22 1999-10-27 ОАО "Ирбитский химико-фармацевтический завод" Способ получения таблеток бромкамфоры рацемической
US6376545B1 (en) 1998-11-10 2002-04-23 Teva Pharmaceutical Industries, Ltd. Dispersible compositions containing L-DOPA ethyl ester
GB9908014D0 (en) 1999-04-08 1999-06-02 Scherer Corp R P Pharmaceutical compositions
US6284270B1 (en) 1999-08-04 2001-09-04 Drugtech Corporation Means for creating a mass having structural integrity
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US8404217B2 (en) 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
WO2001085136A2 (en) 2000-05-10 2001-11-15 Alliance Pharmaceutical Corporation Phospholipid-based powders for drug delivery
US20020001617A1 (en) * 2000-05-26 2002-01-03 Chang-Hyun Lee Rapidly disintegrating tablet and process for the manufacture thereof
US20030185886A1 (en) * 2000-05-26 2003-10-02 Hanmi Pharm. Co., Ltd. Process for the preparation of rapidly disintegrating tablet
GB0028709D0 (en) * 2000-11-24 2001-01-10 S P A Process
US6544552B2 (en) * 2001-01-11 2003-04-08 Particle And Coating Technologies, Inc. Method of producing porous tablets with improved dissolution properties
MXPA03007081A (es) * 2001-02-08 2004-10-15 Pharmacia Corp Medicamento de accion rapida para el tratamiento de disfuncion sexual.
KR20030081472A (ko) * 2001-03-06 2003-10-17 교와 핫꼬 고교 가부시끼가이샤 구강내 속붕괴성 제제
US6509040B1 (en) 2001-06-22 2003-01-21 R.P. Scherer Corporation Fast dispersing dosage forms essentially free of mammalian gelatin
US9358214B2 (en) * 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
JP2005514393A (ja) 2001-12-19 2005-05-19 ネクター セラピューティクス アミノグリコシドの肺への供給
IL164152A0 (en) * 2002-03-26 2005-12-18 Teva Pharma Drug microparticles
WO2004032853A2 (en) * 2002-10-04 2004-04-22 Pharmacia Corporation Compositions and methods for treating sexual dysfunction
WO2004041244A2 (en) * 2002-10-30 2004-05-21 Pharmacia Corporation Oral extended release tablets and methods of making and using the same
US8367111B2 (en) * 2002-12-31 2013-02-05 Aptalis Pharmatech, Inc. Extended release dosage forms of propranolol hydrochloride
AU2004238321B2 (en) * 2003-05-07 2009-08-27 Samyang Biopharmaceuticals Corporation Highly plastic granules for making fast melting tablets
US7390503B1 (en) 2003-08-22 2008-06-24 Barr Laboratories, Inc. Ondansetron orally disintegrating tablets
US8747895B2 (en) * 2004-09-13 2014-06-10 Aptalis Pharmatech, Inc. Orally disintegrating tablets of atomoxetine
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
NZ589750A (en) 2004-10-21 2012-07-27 Aptalis Pharmatech Inc Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
WO2006045830A1 (en) * 2004-10-28 2006-05-04 Pantec Ag A highly porous, fast-disintegrating solid dosage form and its way of manufacturing comprising the preparation of a podwer and a freezedrying step
US20060105038A1 (en) * 2004-11-12 2006-05-18 Eurand Pharmaceuticals Limited Taste-masked pharmaceutical compositions prepared by coacervation
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
GB0516604D0 (en) * 2005-08-12 2005-09-21 Sandoz Ag Rapidly dispersing/disintegrating compositions
US20090068262A1 (en) * 2007-04-04 2009-03-12 Ilan Zalit Rapid dissolution of combination products
EP2170282A4 (en) * 2007-06-27 2014-11-05 Hanmi Pharm Ind Co Ltd METHOD FOR PRODUCING A QUICKLY CRUSHING FORMULATION FOR ORAL ADMINISTRATION AND DEVICE FOR PREPARING AND PACKAGING THE FORMULATION
US20090060983A1 (en) * 2007-08-30 2009-03-05 Bunick Frank J Method And Composition For Making An Orally Disintegrating Dosage Form
AU2008318851B2 (en) * 2007-10-31 2014-04-17 Mcneil-Ppc, Inc. Orally disintegrated dosage form
JP5594484B2 (ja) * 2009-07-06 2014-09-24 杏林製薬株式会社 中空構造を有する錠剤
US8871263B2 (en) * 2009-09-24 2014-10-28 Mcneil-Ppc, Inc. Manufacture of tablet in a die utilizing radiofrequency energy and meltable binder
US8313768B2 (en) 2009-09-24 2012-11-20 Mcneil-Ppc, Inc. Manufacture of tablet having immediate release region and sustained release region
US8858210B2 (en) 2009-09-24 2014-10-14 Mcneil-Ppc, Inc. Manufacture of variable density dosage forms utilizing radiofrequency energy
US20110070286A1 (en) * 2009-09-24 2011-03-24 Andreas Hugerth Process for the manufacture of nicotine-comprising chewing gum and nicotine-comprising chewing gum manufactured according to said process
SG10201407965XA (en) 2009-12-02 2015-02-27 Aptalis Pharma Ltd Fexofenadine microcapsules and compositions containing them
US20110212171A1 (en) * 2010-01-08 2011-09-01 Eurand, Inc. Taste masked topiramate composition and an orally disintegrating tablet comprising the same
US9233491B2 (en) 2012-05-01 2016-01-12 Johnson & Johnson Consumer Inc. Machine for production of solid dosage forms
US9511028B2 (en) 2012-05-01 2016-12-06 Johnson & Johnson Consumer Inc. Orally disintegrating tablet
US9445971B2 (en) 2012-05-01 2016-09-20 Johnson & Johnson Consumer Inc. Method of manufacturing solid dosage form
EP3091966B1 (en) 2014-01-10 2019-07-31 Johnson & Johnson Consumer Inc. Process for making tablet using radiofrequency and lossy coated particles
CN107595789B (zh) 2016-04-21 2021-01-15 阿斯利康(瑞典)有限公司 口腔崩解片
US10493026B2 (en) 2017-03-20 2019-12-03 Johnson & Johnson Consumer Inc. Process for making tablet using radiofrequency and lossy coated particles

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1742515A (en) * 1924-10-08 1930-01-07 Ambrose J Mandell Method of making porous objects
US2887437A (en) * 1956-08-22 1959-05-19 Pfizer & Co C Palatable vitamin tablet containing an amino acid
US3175521A (en) * 1961-02-23 1965-03-30 Schering Corp Apparatus for punching miniature tablets
US3371984A (en) * 1963-09-06 1968-03-05 Colgate Palmolive Co Air freshener
DE1228029C2 (de) * 1964-05-09 1973-05-17 Merck Ag E Verfahren zur Herstellung von Tabletten durch Pressen von Pulvergemischen ohne vorhergehende Granulation
US3450494A (en) * 1967-07-18 1969-06-17 Conrad J Gaiser Amorphous sodium silicate having inherent binding properties and method of producing same
US3639286A (en) * 1968-05-28 1972-02-01 Mario Ballestra Synthetic detergent in bar or cake form and the method to manufacture same
GB1303102A (enExample) * 1969-01-16 1973-01-17
US3719599A (en) * 1969-11-25 1973-03-06 Lepetit Spa Solid lubricant composition and method of preparation
LU60170A1 (enExample) * 1970-01-09 1971-11-18
US3653914A (en) * 1970-03-20 1972-04-04 Alberto Culver Co Production of tablets
US3632778A (en) * 1970-06-10 1972-01-04 Hoffmann La Roche Tablets containing l-dopa
US3739048A (en) * 1971-05-26 1973-06-12 Sumitomo Electric Industries Method of granulating powder
US3789119A (en) * 1971-06-01 1974-01-29 Parke Davis & Co Stabilized molded sublingual nitroglycerin tablets

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2556561A1 (de) * 1975-12-16 1977-06-30 Boehringer Mannheim Gmbh Verfahren zur herstellung von poroesen tabletten
DE2744493A1 (de) * 1976-10-06 1978-04-13 Wyeth John & Brother Ltd Geformter traeger fuer chemikalien und/oder pharmaka
DE3734796A1 (de) * 1986-10-14 1988-04-21 Beaufour Lab Verfahren zur herstellung von loeslichen und/oder zerteilbaren tabletten und nach diesem verfahren erhaltene tabletten
WO2024252015A1 (de) 2023-06-09 2024-12-12 euvorio GmbH Verwendung kohlenhydrathaltiger zusammensetzungen in tablettenform zur behandlung von hypoglykämiezuständen

Also Published As

Publication number Publication date
CH579394A5 (enExample) 1976-09-15
JPS4969819A (enExample) 1974-07-05
SE395366B (sv) 1977-08-15
AT324568B (de) 1975-09-10
US3885026A (en) 1975-05-20
FR2199973A1 (enExample) 1974-04-19
GB1381588A (en) 1975-01-22
FR2199973B1 (enExample) 1979-01-05
IT998618B (it) 1976-02-20

Similar Documents

Publication Publication Date Title
DE2246013A1 (de) Verfahren zur herstellung von poroesen tabletten
DE2556561A1 (de) Verfahren zur herstellung von poroesen tabletten
EP0078430B1 (de) Verfahren zur Herstellung von festen, schnellfreisetzenden Arzneizubereitungen mit Dihydropyridinen
DE3420283A1 (de) Nifedipin-trockenpraeparate und verfahren zu ihrer herstellung
DE60036205T2 (de) Granulat bestehend aus Stärke und Laktose
DE69728857T3 (de) Feste arzneimittel enthaltend trehalose
EP0122574B1 (de) Teilbare Tablette mit verzögerter Wirkstofffreigabe und Verfahren zu deren Herstellung
DD292837A5 (de) Verfahren zur herstellung von cholestyramin-tabletten
DE3633292A1 (de) Pharmazeutische zusammensetzung
DE3505433A1 (de) Direkttablettierhilfsmittel
US4203997A (en) Directly-pressable ascorbic acid-containing granulates
DE69913958T2 (de) Nichtkristalline feste dispergierende Zusammensetzung mit Cefuroximaxetil
DE2741755C2 (de) Überzugsmassen auf Polymerbasis für biologisch aktive Präparate, Verfahren zu ihrer Herstellung sowie mit diesen Überzugsmassen überzogene biologisch aktive Präparate und Verfahren zur Herstellung derselben
EP0468247B1 (de) Verfahren zur Herstellung mechanisch stabiler, gut zerfallender Komprimate aus kleindimensionierten Extrusionspellets mit hohem Etofibratgehalt
US20020142044A1 (en) Pharmaceutical dosage forms with enhanced cohesive and compressiblity properties
DE69010563T3 (de) Wässrige Granulierungslösung und Verfahren zur Tablettengranulierung.
DE2241960C2 (de) Freifließendes Granulat zur Tablettenherstellung
DE60103247T2 (de) Verfahren zur Herstellung von Formulierungen zur Direkttablettierung
DE04078149T1 (de) Stabile feste Zusammensetzung von Enalaprilsalz und dessen Herstellung
US4645664A (en) Microporous powder form polylactides
DE69800357T2 (de) Feste, nicht zerfliessbare formulierung von natrium valproat
DE2415936C2 (enExample)
DE3141498C2 (enExample)
DE3142853C2 (enExample)
DE3045488C2 (enExample)

Legal Events

Date Code Title Description
OHA Expiration of time for request for examination